Role of sialylation in determining the pharmacokinetics of neutrophil inhibitory factor (NIF) in the Fischer 344 rat

Xenobiotica

Volumn 29, Issue 11, 1999, Pages 1141-1155

  Webster, R ^a   Taberner, J ^a   Edgington, A ^a   Guhan, S ^b   Varghese, J ^b   Feeney, H ^b   Blocker, L ^b   Jezequel, S G ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASIALOFETUIN; ASIALOGLYCOPROTEIN; ASIALOGLYCOPROTEIN RECEPTOR; GLYCAN; NEUTROPHIL INHIBITORY FACTOR; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DEGRADATION; DRUG HALF LIFE; INTRAVENOUS DRUG ADMINISTRATION; LIVER PERFUSION; MALE; MOLECULAR WEIGHT; NONHUMAN; PROTEIN PROTEIN INTERACTION; RAT; SIALYLATION;

ANIMALIA;

EID: 0032694575     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982599238010     Document Type: Article

References (28)

1. ASHWELL, G. and KAWASAKI, T., 1978, A protein from mammalian liver that specifically binds galactose terminated glycoproteins. Methods in Enzymology, 50, 287-288.
2. BOCCI, V., 1976, The role of sialic acid in determining the life span of circulating cells and proteins. Experientia, 32, 135-140.
3. BOCCI, V., SATOH, Y., PACINI, A., PESSINA, G. P., PAULESU, L. and MUSCETTOLA, M., 1987, Metabolic behaviour of recombinant interferons β. Medicinal Science Research, 15, 187-188.
4. DAI, J., DENT, W., ATKINSON, J. W., COX, J. G. and DEMBINSKI, T. C., 1996, Comparison of three immunoassay kits for serum thyroglobulin in patients with thyroid cancer. Clinical Biochemistry, 29, 461-465.
5. DAVIES, B. and MORRIS, T., 1993, Physiological parameters in laboratory animals and humans. Pharmaceutical Research, 7, 1093-1095.
6. FESTING, M. F., 1993, Genetic variation in outbred rats and mice and its implications for toxicology screening. Journal of Experimental Animal Science, 35, 210-220.
7. GARDNER, I. B., WALKER, D. K., LENNARD, M. S., SMITH, D. A. and TUCKER, G. T., 1995, Comparison of the disposition of two novel combined thromboxane synthase inhibitors/thromboxane A2 receptor antagonists in the isolated perfused rat liver. Xenobiotica, 25, 185-187.
8. JIANG, N., CHOPP, M. and CHAHWALA, S., 1998, Neutrophil inhibitory factor treatment of focal cerebral ischemia in the rat. Brain Research, 788, 25-34.
9. JIANG, N., MOYLE, M., SOULE, H. R., ROTE, W. E. and CHOPP, M., 1995, Neutrophil inhibitory factor is neuroprotective after focal ischemia in rats. Annals of Neurology, 38, 935-942.
10. KNIPPING, G., GOGG-FOSSOLTER, G., FROHNWIESSER, B., KREMPLER, F., KOSTNER, G. M. and MALLE, E., 1997, Quantification of apolipoprotein D by an immunoassay with time-resolved fluoresence spectroscopy. Journal of Immunological Methods, 202, 85-95.
11. LEE, Y. C., TOWNSEND, R. R., HARDY, M. R., LONNGREN, J., ARNARP, J., HARALDSSON, M. and LONN, H., 1993, Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc Lectin. Journal of Biological Chemistry, 258, 199-202.
12. LEFORT, G. P., STOLK, J. M. and NISULA, B. C., 1984, Evidence that desialylation and uptake by hepatic receptors for galactose terminated glycoproteins are immaterial to the metabolism of human choriogonadotrophin in the rat. Endocrinology, 115, 1151-1557.
13. MORDENTI, J., CHEN, S. A., MOORE, J. A., FERRAIOLO, B. L. and GREEN, J. D., 1991, Interspecies scaling of clearance and volume of distribution data for five therapeutic proteins. Pharmaceutical Research, 8, 1351-1359.
14. MORELL, A. G., GREGORIADIS, G., SCHEINBERG, I. H., HICKMAN, J. and ASHWELL, G., 1971, The role of sialic acid in determining the survival of glycoproteins in the circulation. Journal of Biological Chemistry, 246, 1461-1467.
15. MORELL, A. G., IRVINE, R. A., STERNLIEB, I., SCHEINBERG, I. H. and ASHWELL, G., 1968, Physical and chemical studies on ceruloplasmin. V. Metabolic studies on sialic acid free ceruloplasmin in vivo. Journal of Biological Chemistry, 243, 155-159.
16. MOYLE, M., FOSTER, D. L., McGRATH, D. E., BROWN, S. M., LAROCHE, Y., DE MEUTTER, J., STANSSENS, P., BOGOWITZ, C. A., FRIED, V. A., ELY, J. A., SOULE, H. R. and VLASUK, G. P., 1994, A hookworm glycoprotein that inhibits neutrophil function is a ligand of the integrin CD11b/CD18*. Journal of Biological Chemistry, 269, 10008-10015.
17. RICHTER, W. F., GALLATI, H. and SCHILLER, C. D., 1999, Animal pharmacokinetics of the tumar necrosis factor receptor-immunoglobulin fusion protein Lenercept and their extrapolation to humans. Journal of the American Society of Pharmacology and Experimental Therapeutics, 27, 21-25.
18. RONNBLOM, L. E., PERERS, A., VALLIN, H. S., ERIKSSON, I., OSTERLIND, A., CEDERBLAD, B. and ALM, G., 1997, Detection of serum interferon-α by dissociation-enhanced lanthanide fluoroimmunoassay; studies of patients with acute viral and bacterial infections. APMIS, 105, 531-536.
19. STRANG, E., ROOS, N., SCHLUETER, M., BERG, T. and KRAUSE, J., 1992, Evidence for a carbohydrate-independent endocytosis of tissue-type plasminogen activator. Biochemical Journal, 285, 799-804.
20. TAVASSOLI, M., 1985, Liver endothelium binds, transports and desialylates ceruloplasmin which is then recognised by galactosyl receptors of the hepatocytes. Transactions of the Association of American Physicians, 98, 370-377.
21. TAVASSOLI, M., KISHIMOTO, T. and KATAOKA, M., 1986, Liver endothelium mediates the hepatocytes uptake of ceruloplasmin. Journal of Cell Biology, 102, 1298-1303.
22. 14C-labeled ceruloplasmin. Journal of Biological Chemistry, 245, 759-766.
23. VAN DEN HAMER, C. J. A., MORELL, A. G., SCHEINBERG, I. H., HICKMAN, J. and ASHWELL, G., 1970b, Physical and chemical studies on ceruloplasmin. IX The role of galactosyl residues in the clearance of ceruloplasmin from the circulation. Journal of Biological Chemistry, 245, 4397-4402.
24. VAN DER SLUIJS, P., OOSTING, R., WEITERING, J. G., HARDONK, M. J. and MEIJER, D. K. F., 1985, Biliary excretion of FITC metabolites after administration of FITC labelled asiolo orosomuciod as a measure of lysosomal proteolysis. Biochemical Pharmacology, 34, 1399-1405.
25. VENERANDO, B., FOIRILLA, A., CROCI, G. L. and TETTAMANTI, G., 1997, Presence in human erythrocyte membrane of a novel form of sialidase acting at neutral pH. Blood, 90, 2047-2056.
26. WARREN, L., 1959, The thiobarbituric acid assay of sialic acids. Journal of Biological Chemistry, 234, 1971-1975.
27. WICHER, I., SATTLER, W., IBOVNIK, A., KOSTNER, G. M., ZECHNER, R. and MALLE, E., 1996, Quantification of lipoprotein lipase (LPL) by dissociation-enhanced lanthanide fluorescence immunoassay. Comparison of immunoreactivity of LPL mass and enzyme activity of LPL. Journal of Immunological Methods, 192, 1-11.
28. WOLFE, S. L., 1993, Protein sorting, distribution, secretion and endocytosis. In S. L. Wolfe (ed.), Molecular and Cellular Biology (Belmonte: Wadworth), pp. 825-873.